Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28969636 | 0.97 | CA2 (0.33) | CA2TSHRTHPOTDP1 | |
| SCHEMBL29022917 | 0.97 | CA2 (0.33) | CA2TSHRTHPOTDP1 | |
| SCHEMBL28980833 | 0.97 | CA2 (0.33) | CA2TSHRTHPOTDP1 | |
| SCHEMBL4363246 | 0.81 | CA2 (0.44) | CA2TSHRTDP1 | |
| SCHEMBL999439 | 0.78 | ALDH1A1 (0.48) | CA2TSHRTDP1 | |
| SCHEMBL28697109 | 0.76 | ALDH1A1 (0.46) | CA2TSHRTDP1 | |
| SCHEMBL28285490 | 0.76 | ALDH1A1 (0.46) | CA2TSHRTDP1 | |
| SCHEMBL114521 | 0.75 | — | — | |
| SCHEMBL28092897 | 0.75 | CA2 (0.39) | CA2TSHRTDP1 | |
| SCHEMBL27543204 | 0.75 | ALDH1A1 (0.39) | CA2TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947123-B2 | Synthetic caustic composition | FLUID ENERGY GROUP LTD. (CA) | 2021-03-16 | — | — | US | claimed |
| US-20190144741-A1 | NOVEL SYNTHETIC CAUSTIC COMPOSITION | HSBC BANK MIDDLE EAST LIMITED (AE) | 2019-05-16 | — | — | US | claimed |
| US-20220372398-A1 | High Alkaline High Foam Cleaners with Controlled Foam Life | HSBC BANK MIDDLE EAST LIMITED (AE) | 2022-11-24 | — | — | US | disclosed |
| WO-2022236397-A1 | HIGH ALKALINE HIGH FOAM CLEANERS WITH CONTROLLED FOAM LIFE | FLUID ENERGY GROUP LTD. (CA) | 2022-11-17 | — | — | WO | disclosed |
| US-10947123-B2 | Synthetic caustic composition | FLUID ENERGY GROUP LTD. (CA) | 2021-03-16 | — | — | US | disclosed |
| US-20190144741-A1 | NOVEL SYNTHETIC CAUSTIC COMPOSITION | HSBC BANK MIDDLE EAST LIMITED (AE) | 2019-05-16 | — | — | US | disclosed |
| EP-2063881-B1 | A COMPOSITION AND METHOD FOR THE EFFICACIOUS AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | KO YOUNG HEE (US) | 2019-05-08 | — | — | EP | disclosed |
| US-7754693-B2 | mixing a buffers, a sugar and an inhibitor of cancer cell ATP production, then diluting with a saline solution and administering the diluted mixture to a patient having a cancerous tumor that is positron emission tomography (PET) positive | KODISCOVERY, LLC | 2010-07-13 | — | — | US | disclosed |
| CN-1768136-B | Agar-digesting enzyme and utilization thereof | JAPAN OCEAN SCIENCE & TECH CT | 2010-05-05 | — | — | CN | disclosed |
| EP-2063881-A2 | A COMPOSITION AND METHOD FOR THE EFFICACIOUS AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | Ko, Young Hee (US) | 2009-06-03 | — | — | EP | disclosed |
| US-20080124568-A1 | New flux composition and process for use thereof | GLOBALFOUNDRIES INC. (KY) | 2008-05-29 | — | — | US | disclosed |
| WO-2007097989-A2 | A COMPOSITION AND METHOD FOR THE EFFICACIOUS AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | KO YOUNG HEE (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070203074-A1 | Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer | KODISCOVERY, LLC | 2007-08-30 | — | — | US | disclosed |
| CN-1768136-A | Agar-digesting enzyme and utilization thereof | INDEPENDENT ADMINISTRATIVE INSTITUTION JAPAN AGENCY FOR MARINE EARTH SCI & TECH (JP) | 2006-05-03 | — | — | CN | disclosed |
| CN-1205198-C | Cyclic ketone derivative and pharmaceutical use thereof | TORAY INDUSTRIES (JP) | 2005-06-08 | — | — | CN | disclosed |
| CN-1242770-A | Cyclic ketone derivative and pharmaceutical use thereof | TORAY INDUSTRIES (JP) | 2000-01-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203074-A1 | Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer | HK1, KHK, SLC5A1 | CA2 111/4885TSHR 3409/4885THPO 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.